www.fdanews.com/articles/131662-biotronik-enrolls-first-patient-in-drug-eluting-balloon-therapy-clinical-study
Biotronik Enrolls First Patient in Drug-Eluting Balloon Therapy Clinical Study
November 4, 2010
Biotronik AG, a European manufacturer of therapy solutions for vascular intervention, announced the first enrollment in the BIOLUX P-I clinical study.
Euroinvestor
Euroinvestor